K74.0 Hepatic fibrosis

Name of the Condition

• Hepatic Fibrosis (ICD-10-CM Code: K74.0)

Summary

Hepatic fibrosis is a condition marked by the accumulation of scar tissue in the liver, resulting from chronic injury or inflammation. This scarring can impair liver function over time, though the extent of damage varies. The code K74.0 specifically denotes hepatic fibrosis without cirrhosis, distinguishing it from more advanced liver disease.

Causes

Hepatic fibrosis typically develops as a response to ongoing liver damage. Common triggers include chronic viral hepatitis (e.g., hepatitis B or C), long-term alcohol use, non-alcoholic fatty liver disease (NAFLD), and autoimmune liver conditions. Prolonged exposure to toxins or certain medications may also contribute.

Risk Factors

• Chronic viral hepatitis infections
• Excessive alcohol consumption
• Obesity and metabolic syndrome
• Type 2 diabetes
• High cholesterol or triglycerides
• Genetic predispositions to liver disease

Symptoms

Early stages of hepatic fibrosis often present with no symptoms. As fibrosis progresses, signs may include:

• Fatigue
• Mild abdominal discomfort
• Unexplained weight loss
• Jaundice (yellowing of skin or eyes)
• Swelling in the legs or abdomen (edema/ascites)
• Easy bruising or bleeding

Diagnosis

Diagnosis involves a combination of clinical evaluation and testing. Blood tests assess liver function and markers of fibrosis. Imaging studies (e.g., ultrasound, MRI, or CT) visualize liver structure. A liver biopsy or elastography may be used to confirm the extent of scarring.

Treatment Options

Treatment focuses on addressing the underlying cause to slow or halt fibrosis progression. This may include antiviral therapy for hepatitis, alcohol cessation, weight management for NAFLD, or medications to manage autoimmune conditions. In advanced cases, liver transplantation may be considered.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and the stage of fibrosis at diagnosis. Early intervention can stabilize or improve liver function, but untreated fibrosis may progress to cirrhosis. Regular follow-up with liver function tests and imaging is recommended to monitor disease activity.

Complications

If left untreated, hepatic fibrosis can lead to:

• Cirrhosis (severe scarring)
• Liver failure
• Portal hypertension (increased blood pressure in liver vessels)
• Esophageal varices (enlarged veins in the esophagus)
• Hepatocellular carcinoma (liver cancer)

Lifestyle & Prevention

• Limit alcohol intake or avoid it entirely
• Maintain a healthy weight and manage metabolic conditions
• Get vaccinated for hepatitis A and B
• Avoid exposure to liver toxins (e.g., certain chemicals or medications)
• Follow a balanced diet rich in fruits, vegetables, and whole grains

When to Seek Professional Help

Consult a healthcare provider if you experience persistent fatigue, jaundice, unexplained weight loss, or abdominal swelling. Early evaluation is critical for managing underlying causes and preventing progression.

Tips for Medical Coders

Use K74.0 for documentation of hepatic fibrosis without cirrhosis. Ensure clinical notes specify the absence of cirrhosis to support this code. Document the underlying cause (e.g., hepatitis, alcohol use) when available, as it may impact additional coding or treatment planning. Verify that the diagnosis aligns with the clinical presentation to avoid miscoding.